314 related articles for article (PubMed ID: 30707246)
21. Anti-Xa activity by weight in critically ill patients receiving unfractionated heparin for venous thromboembolism prophylaxis.
Aggarwal MV; Jarrell AS; Gilmore VT; Aboagye JK; Haut ER; Hobson DB; Lau BD; Kickler T; Kraus PS; Shaffer DL; Shermock KM; Streiff MB; Zheng G; Kruer RM
J Crit Care; 2019 Aug; 52():180-185. PubMed ID: 31078999
[TBL] [Abstract][Full Text] [Related]
22. Venous thromboembolism prophylaxis in medical ICU patients in Asia (VOICE Asia): a multicenter, observational, cross-sectional study.
Parikh KC; Oh D; Sittipunt C; Kalim H; Ullah S; Aggarwal SK;
Thromb Res; 2012 Apr; 129(4):e152-8. PubMed ID: 22326367
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.
Kociol RD; Hammill BG; Hernandez AF; Klaskala W; Mills RM; Curtis LH; Fonarow GC
Clin Cardiol; 2011 Nov; 34(11):682-8. PubMed ID: 22057910
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill Patient.
Reynolds PM; Van Matre ET; Wright GC; McQueen RB; Burnham EL; Ho PJM; Moss M; Vandivier RW; Kiser TH;
Pharmacotherapy; 2019 Mar; 39(3):232-241. PubMed ID: 30592541
[TBL] [Abstract][Full Text] [Related]
25. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
Lewis TC; Cortes J; Altshuler D; Papadopoulos J
J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
[TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism prophylaxis in critically ill patients.
Boonyawat K; Crowther MA
Semin Thromb Hemost; 2015 Feb; 41(1):68-74. PubMed ID: 25594495
[TBL] [Abstract][Full Text] [Related]
27. Systematic Review of Safety and Cost-Effectiveness of Venous Thromboembolism Prophylaxis Strategies in Patients Undergoing Craniotomy for Brain Tumor.
Algattas H; Damania D; DeAndrea-Lazarus I; Kimmell KT; Marko NF; Walter KA; Vates GE; Jahromi BS
Neurosurgery; 2018 Feb; 82(2):142-154. PubMed ID: 28402497
[TBL] [Abstract][Full Text] [Related]
28. Failure of chemical thromboprophylaxis in critically ill medical and surgical patients with sepsis.
Hanify JM; Dupree LH; Johnson DW; Ferreira JA
J Crit Care; 2017 Feb; 37():206-210. PubMed ID: 27969572
[TBL] [Abstract][Full Text] [Related]
29. Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey.
Cook D; McMullin J; Hodder R; Heule M; Pinilla J; Dodek P; Stewart T;
Crit Care; 2001 Dec; 5(6):336-42. PubMed ID: 11737922
[TBL] [Abstract][Full Text] [Related]
30. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
Akl EA; Rohilla S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann HJ
Cochrane Database Syst Rev; 2008 Jan; (1):CD006649. PubMed ID: 18254108
[TBL] [Abstract][Full Text] [Related]
31. Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review.
Ribic C; Lim W; Cook D; Crowther M
J Crit Care; 2009 Jun; 24(2):197-205. PubMed ID: 19327323
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism prophylaxis in critically ill patients.
McLeod AG; Geerts W
Crit Care Clin; 2011 Oct; 27(4):765-80, v. PubMed ID: 22082513
[TBL] [Abstract][Full Text] [Related]
33. Surgical venous thromboembolism prophylaxis: clinical practice update.
Segon YS; Summey RD; Slawski B; Kaatz S
Hosp Pract (1995); 2020 Dec; 48(5):248-257. PubMed ID: 32589468
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the use of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients.
Du Plessis JA; Van Blydenstein SA; Wong M
S Afr Med J; 2020 Feb; 110(3):235-242. PubMed ID: 32657702
[TBL] [Abstract][Full Text] [Related]
35. European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care.
Duranteau J; Taccone FS; Verhamme P; Ageno W;
Eur J Anaesthesiol; 2018 Feb; 35(2):142-146. PubMed ID: 29112545
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Venous Thromboembolism Prophylactic Measures Post Coronary Artery Bypass Graft Surgery.
Wilsey HA; Pandya K; Beavers C; Xiaoshu L; Ather A
Am J Cardiovasc Drugs; 2019 Dec; 19(6):589-595. PubMed ID: 31203501
[TBL] [Abstract][Full Text] [Related]
37. Differences between low-molecular-weight and unfractionated heparin for venous thromboembolism prevention following ischemic stroke: a metaanalysis.
Shorr AF; Jackson WL; Sherner JH; Moores LK
Chest; 2008 Jan; 133(1):149-55. PubMed ID: 17925410
[TBL] [Abstract][Full Text] [Related]
38. Unfractionated heparin or low-molecular-weight heparin for venous thromboembolism prophylaxis after hepatic resection: A meta-analysis.
Zhang W; Wei X; Yang S; Du C; Hu B
Medicine (Baltimore); 2022 Nov; 101(46):e31948. PubMed ID: 36401460
[TBL] [Abstract][Full Text] [Related]
39. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.
Ra G; Thanabalan R; Ratneswaran S; Nguyen GC
J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817
[TBL] [Abstract][Full Text] [Related]
40. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
